## Abstract Burkitt lymphomas (BL) that arise in HLA‐A11‐positive individuals are characterized by selective loss/down‐regulation of the HLA AII polypeptide. We have investigated the molecular basis of such down‐regulation by comparing 5 pairs of BL lines and Epstein‐Barr virus (EBV)‐transformed ly
Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines
✍ Scribed by Maria G. Masucic; Nico J. Stam; Sigurbjörg Torsteinsdottir; Jaques J. Neefjes; George Klein; Hidde L. Ploegh
- Book ID
- 113134342
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 605 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0008-8749
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Uveal melanoma is the most common primary intra-ocular tumor in adults and has a high mortality rate due to liver metastases, for which no effective treatment is available. To investigate whether immunotherapy might be feasible in uveal melanoma, the HLA class I surface expression of 6 uveal melanom
HLA class-I expression has been investigated by biochemical methods in 14 Burkitt lymphoma (BL) cell lines and the corresponding Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) derived from the same individuals. Selective down-regulation of one or more HLA class-I specificities
Malignant transformation is often associated with genetic alterations providing tumor cells with mechanisms for escape from immune surveillance. Human and murine tumors of various origin as well as in vitro models of viral and oncogenic transformation express reduced levels of major histocompatibili